Clinical Characteristics and Treatment of Postmenopausal Breast Cancer Patients Receiving AI Therapy, by Presence or absence of AI-Related musculoskeletal adverse eventsevents group and control by PCR-based TaqMan assays.
收藏NIAID Data Ecosystem2026-03-07 收录
数据链接：
官方服务：
资源简介：
Note: AI = aromatase inhibitor; OR = odds ratio; ER = estrogen receptor; PR = progesterone receptor.
创建时间：
2013-07-19
